CDH3 and cancer: Despite not having found any alteration in the β1 integrin levels upon P-cadherin inhibition, we do not exclude the possibility that β1 integrin subunit is also implicated in the maintenance/acquisition of cancer stem cell and invasive properties, as this is the other major partner of α6 integrin, constituting an important laminin receptor.